Skip to main content

Data Explorer

Research historical outbreak investigations and the full recall archive, with charts, trends, and advanced filters. Looking for what's happening right now instead? See current Health Alerts.

Recall totals

All FDA and USDA recalls in Public Health Trace, June 2012 to September 2026.

37,115
Total recall recordsAll FDA and USDA recalls in Public Health Trace
9,793
Class I recallsReasonable probability of serious health consequences
24,343
Class II recallsTemporary or medically reversible health consequences
2,887
Class III recallsNot likely to cause adverse health consequences

Quick insights

A snapshot of the most notable patterns across all recorded FDA and USDA recalls.

Most recalled product100 vegetarian Fenugreek Capsules 90 count, 600mg, packaged in 150cc Amber Glass Packer with White Polypropylene Cap. 53 recalls
Most common hazardLack of Assurance of Sterility 2,072 recalls
Most affected stateHawaii 200 recalls mention this state

Download matching recalls as CSV

CSV exports include up to 5,000 matching rows (applying your current filters), not the full dataset if it's larger.

Filters
Recall details
Location
Date range
Sort results
Clear filters
Metric
View
Recalls announced by month (Year to date)

A chart of recalls grouped by month.

Download CSV

Source: FDA and USDA public dataLast updated

Summary (Year to date)

  • 1,527 recalls have been announced year to date.
  • Aug 2026 was 24% lower than the previous complete period (Jul 2026: 240).
  • The highest complete period was Jun 2026 (297).
  • Sep 2026 is incomplete and not included in the figures above.
  • Complete data
  • Incomplete
Recalls by class

A bar chart of the total number of recalls in this dataset by recall class.

Recalls by class
ClassRecalls
Class II24,343
Class I9,793
Class III2,887
Not Yet Classified1
Download CSV
Recalls by class
ClassRecalls
Class II24,343
Class I9,793
Class III2,887
Not Yet Classified1

Showing 6,461–6,480 of 22,138 recalls

FDA Recall Terminated Historical recordClass II

Losartan Potassium and Hydrochlorothiazide Tablets USP, 100 mg/12.5 mg a) 30-count bottles (NDC# 68180-216-06) b) 90-count bottles (NDC# 68180-216-09), Rx Only, Manufactured By: Lupin Limited, Pithampur, India, MFG For: Lupin Pharmaceuticals, Inc. Baltimore, Maryland 21202, USA

by Lupin Pharmaceuticals Inc.

Reason
CGMP Deviations- AZIDO Impurity levels observed to be above acceptable limits
Published
May 11, 2022
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Losartan Potassium and Hydrochlorothiazide Tablets USP, 100 mg/25 mg a) 30-count bottles (NDC# 68180-217-06) b) 90-count bottles (NDC# 68180-217-09), Rx Only, Manufactured By: Lupin Limited, Pithampur, India, MFG For: Lupin Pharmaceuticals, Inc. Baltimore, Maryland 21202, USA

by Lupin Pharmaceuticals Inc.

Reason
CGMP Deviations- AZIDO Impurity levels observed to be above acceptable limits
Published
May 11, 2022
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Losartan Potassium and Hydrochlorothiazide Tablets USP, 50 mg/12.5 mg a) 30-count bottles (NDC# 68180-215-06) b) 90-count bottles (NDC# 68180-215-09), Rx Only, Manufactured By: Lupin Limited, Pithampur, India, MFG For: Lupin Pharmaceuticals, Inc. Baltimore, Maryland 21202, USA.

by Lupin Pharmaceuticals Inc.

Reason
CGMP Deviations- AZIDO Impurity levels observed to be above acceptable limits
Published
May 11, 2022
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Losartan Potassium Tablets USP, 100 mg, a) 90-count bottles (NDC# 68180-378-03), b) 1000-count bottles (NDC# 68180-378-09), Rx Only, Manufactured By: Lupin Limited, Pithampur, India, MFG For: Lupin Pharmaceuticals, Inc. Baltimore, Maryland 21202, USA.

by Lupin Pharmaceuticals Inc.

Reason
CGMP Deviations- AZIDO Impurity levels observed to be above acceptable limits
Published
May 11, 2022
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Losartan Potassium Tablets USP, 50 mg, a) 90-count bottles (NDC# 68180-377-03), b) 1000-count bottles (NDC# 68180-377-09), Rx Only, Manufactured By: Lupin Limited, Pithampur, India, MFG For: Lupin Pharmaceuticals, Inc. Baltimore, Maryland 21202, USA.

by Lupin Pharmaceuticals Inc.

Reason
CGMP Deviations- AZIDO Impurity levels observed to be above acceptable limits
Published
May 11, 2022
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Losartan Potassium Tablets USP, 25 mg, a) 90-count bottles (NDC# 68180-376-03), b) 1000-count bottles (NDC# 68180-376-09), Rx Only, Manufactured By: Lupin Limited, Pithampur, India, MFG For: Lupin Pharmaceuticals, Inc. Baltimore, Maryland 21202, USA.

by Lupin Pharmaceuticals Inc.

Reason
CGMP Deviations- AZIDO Impurity levels observed to be above acceptable limits
Published
May 11, 2022
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Losartan Potassium & Hydrochlorothiazide Tablets, USP, 100 mg/12.5 mg, a) 30-count bottles (NDC# 33342-051-07), b) 90-count bottles (NDC # 33342-051-10) c) 1000-count bottles (NDC # 33342-051-44), Rx Only, MFR: Macleods Pharma USA, Inc. Plainsboro, NJ 08536

by Macleods Pharma Usa Inc

Reason
CGMP Deviations- AZIDO Impurity levels observed to be above acceptable limits
Published
May 11, 2022
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Losartan Potassium & Hydrochlorothiazide Tablets, USP, 100 mg/25 mg, a) 30-count bottles (NDC# 33342-052-07), b) 90-count bottles (NDC # 33342-052-10) c) 1000-count bottles (NDC # 33342-052-44), Rx Only, MFR: Macleods Pharma USA, Inc. Plainsboro, NJ 08536

by Macleods Pharma Usa Inc

Reason
CGMP Deviations- AZIDO Impurity levels observed to be above acceptable limits
Published
May 11, 2022
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Losartan Potassium & Hydrochlorothiazide Tablets, USP, 50 mg/12.5 mg, a) 30-count bottles (NDC# 33342-050-07), b) 90-count bottles (NDC # 33342-050-10) c) 1000-count bottles (NDC # 33342-050-44), Rx Only, MFR: Macleods Pharma USA, Inc. Plainsboro, NJ 08536

by Macleods Pharma Usa Inc

Reason
CGMP Deviations- AZIDO Impurity levels observed to be above acceptable limits
Published
May 11, 2022
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Losartan Potassium Tablets, USP, 100 mg, a) 30-count bottles (NDC # 33342-046-07), b) 90-count bottles (NDC # 33342-046-10), c) 1000-count bottles (NDC # 33342-046-44), Rx Only, MFR: Macleods Pharma USA, Inc. Plainsboro, NJ 08536

by Macleods Pharma Usa Inc

Reason
CGMP Deviations- AZIDO Impurity levels observed to be above acceptable limits
Published
May 11, 2022
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Losartan Potassium Tablets, USP, 50 mg, a) 30-count bottles (NDC # 33342-045-07), b) 90-count bottles (NDC # 33342-045-10), c) 1000-count bottles (NDC # 33342-045-44), Rx Only, MFR: Macleods Pharma USA, Inc. Plainsboro, NJ 08536

by Macleods Pharma Usa Inc

Reason
CGMP Deviations- AZIDO Impurity levels observed to be above acceptable limits
Published
May 11, 2022
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Losartan Potassium Tablets, USP, 25 mg, a) 90-count bottles (NDC # 33342-044-10), b) 1000-count bottles (NDC # 33342-044-44), Rx Only, MFR: Macleods Pharma USA, Inc. Plainsboro, NJ 08536

by Macleods Pharma Usa Inc

Reason
CGMP Deviations- AZIDO Impurity levels observed to be above acceptable limits
Published
May 11, 2022
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Vancomycin HCl 1.5 g in 0.9% Sodium Chloride, 500 mL bags, Rx only, SCA Pharmaceuticals Windsor, CT 06095, NDC 70004-0924-44

by SCA Pharmaceuticals

Reason
CGMP Deviations
Published
May 11, 2022
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Fentanyl 2mcg/ml and Bupivacaine 0.125% in 0.9% Sodium Chloride 100 mL bags, Rx only, SCA Pharmaceuticals Windsor, CT 06095, NDC 70004-0231-32

by SCA Pharmaceuticals

Reason
CGMP Deviations
Published
May 11, 2022
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Norepinephrine 8mg in 0.9% Sodium Chloride 250 mL bag, Rx only, SCA Pharmaceuticals Windsor, CT 06095, NDC 70004-078-40

by SCA Pharmaceuticals

Reason
CGMP Deviations
Published
May 11, 2022
Distribution
Nationwide

View recall →

FDA Recall United States Terminated Historical recordClass I

A & C Best Food Trading

Product
BEAUTIFUL AND DELICIOUS TASTE; TOP SAVOR; Wife Plum; Net wt.…
Reason
Product contains undeclared sulfites and unallowed dye - Amaranth (E123) - Acid Red 27
Published
May 11, 2022
Distribution
Multiple states

View recall →

FDA Recall United States Terminated Historical recordClass II

A & C Best Food Trading

Product
Olive King Olives; 14 oz; packaged in clear and green plasti…
Reason
Product contains undeclared sulfites.
Published
May 11, 2022
Distribution
Multiple states

View recall →

FDA Recall United States Terminated Historical recordClass I

A & C Best Food Trading

Product
Olive; TOP SAVOR Licorice Flavored Olive; Net wt: 500g (17.6…
Reason
Product contains undeclared sulfites.
Published
May 11, 2022
Distribution
Multiple states

View recall →

FDA Recall United States Terminated Historical recordClass I

Bakkavor Foods USA Inc.

Product
WHOLE FOODS MARKET red lentil dal NET WT. 12 OZ (340g) DISTR…
Reason
Possible Listeria monocytogenes in product
Published
May 11, 2022
Distribution
Product was shipped to the following sta…

View recall →

FDA Recall Terminated Historical recordClass I

Insulin Glargine (insulin glargine-yfgn) Injection, 100 units/mL (U-100), packaged in a 10 mL Multiple-Dose vial inside a carton, Rx only, Manufactured by: Mylan Pharmaceuticals Inc., Morgantown, WV 26505, Manufactured for: Mylan Specialty L.P., Morgantown, WV 26505, NDC 49502-393-80

by MYLAN PHARMACEUTICALS INC

Reason
Labeling: Missing label on the vial
Published
May 4, 2022
Distribution
Nationwide

View recall →

Data last updated:

Recall records are summarized from official FDA and USDA sources. Notices may be updated, reclassified, terminated, or withdrawn. Always review the linked official notice for the most current instructions. Read the full medical disclaimer.